Lorenzo Fagotti1, Jakub Tatka1, Mauro Jose Costa Salles2, Marcelo C Queiroz3. 1. Steadman Philippon Research Institute, Vail, CO, USA. 2. Division of Infectious Diseases, Department of Internal Medicine, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil. 3. Department of Orthopaedic Surgery, Santa Casa de São Paulo School of Medical Sciences, São Paulo, Brazil. marcelo@institutoqueiroz.com.br.
Abstract
PURPOSE OF REVIEW: Although a two-stage exchange revision is reported to have a high success rate, this strategy may fail as a treatment for prosthetic joint infection (PJI). When it does, resection arthroplasty, arthrodesis, amputation, and chronic antibiotic suppression may play a role. The purpose of this review is to determine which are the main risk factors for a two-stage exchange failure and to analyze the indications and results of resection arthroplasty, arthrodesis, amputation, and antibiotic chronic suppression for PJI. RECENT FINDINGS: Recent literature demonstrates that the main risk factors for a two-stage exchange failure are as follows: hemodialysis, obesity, multiple previous procedures, diabetes mellitus, corticosteroid therapy, hypoalbuminemia, immunosuppression, rheumatological conditions, coagulation disorders, and infection due to multidrug-resistant (MDR) bacteria or fungal species. Regarding microorganisms, besides Staphylococcus aureus, Streptococcus spp., Enterobacteriaceae species such as Klebsiella pneumoniae and Enterobacter sp., Pseudomonas aeruginosa, or Acinetobacter baumannii, and fungus including Candida sp. are also considered risk factors for a two-stage exchange failure. Resection arthroplasty, arthrodesis, and amputation have a limited role. Chronic suppression is an option for high-risk patients or unfeasible reconstruction. In summary, we report the main risk factors for a two-stage exchange failure and alternative procedures when it occurs. Future research on patient-specific risk factors for a two-stage exchange may aid surgical decision-making and optimization of outcomes.
PURPOSE OF REVIEW: Although a two-stage exchange revision is reported to have a high success rate, this strategy may fail as a treatment for prosthetic joint infection (PJI). When it does, resection arthroplasty, arthrodesis, amputation, and chronic antibiotic suppression may play a role. The purpose of this review is to determine which are the main risk factors for a two-stage exchange failure and to analyze the indications and results of resection arthroplasty, arthrodesis, amputation, and antibiotic chronic suppression for PJI. RECENT FINDINGS: Recent literature demonstrates that the main risk factors for a two-stage exchange failure are as follows: hemodialysis, obesity, multiple previous procedures, diabetes mellitus, corticosteroid therapy, hypoalbuminemia, immunosuppression, rheumatological conditions, coagulation disorders, and infection due to multidrug-resistant (MDR) bacteria or fungal species. Regarding microorganisms, besides Staphylococcus aureus, Streptococcus spp., Enterobacteriaceae species such as Klebsiella pneumoniae and Enterobacter sp., Pseudomonas aeruginosa, or Acinetobacter baumannii, and fungus including Candida sp. are also considered risk factors for a two-stage exchange failure. Resection arthroplasty, arthrodesis, and amputation have a limited role. Chronic suppression is an option for high-risk patients or unfeasible reconstruction. In summary, we report the main risk factors for a two-stage exchange failure and alternative procedures when it occurs. Future research on patient-specific risk factors for a two-stage exchange may aid surgical decision-making and optimization of outcomes.
Authors: Camilo Restrepo; Steven Schmitt; David Backstein; Bryan T Alexander; Maja Babic; Barry D Brause; John L Esterhai; Robert P Good; Peter H Jørgensen; Paul Lee; Camelia Marculescu; Claudio Mella; Carsten Perka; Aidin Eslam Pour; Harry E Rubash; Tomoyuki Saito; Rolando Suarez; Robert Townsend; I Remzi Tözün; Michel P J Van den Bekerom Journal: J Arthroplasty Date: 2013-10-01 Impact factor: 4.757
Authors: M Mashfiqul A Siddiqui; Ngai Nung Lo; Shaifuzain Ab Rahman; Pak Lin Chin; Shi-Lu Chia; Seng Jin Yeo Journal: J Arthroplasty Date: 2012-06-06 Impact factor: 4.757
Authors: William P H Charlton; William J Hozack; Marco A Teloken; Rajesh Rao; Gina Ann Bissett Journal: Clin Orthop Relat Res Date: 2003-02 Impact factor: 4.176
Authors: A C Steinicke; J Schwarze; G Gosheger; B Moellenbeck; T Ackmann; C Theil Journal: Arch Orthop Trauma Surg Date: 2022-01-04 Impact factor: 3.067
Authors: Andreas Enz; Silke C Mueller; Philipp Warnke; Martin Ellenrieder; Wolfram Mittelmeier; Annett Klinder Journal: J Fungi (Basel) Date: 2021-05-21